中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

亚洲地区原发性胆汁性肝硬化的诊疗现状

范雪 贾继东

引用本文:
Citation:

亚洲地区原发性胆汁性肝硬化的诊疗现状

详细信息
  • 中图分类号: R575.2

Diagnosis and treatment of primary biliary cirrhosis in Pacific Asia region

  • [1]Boberg KM, Aadland E, Jahnsen J, et al.Incidence and prevalenceof primary biliary cirrhosis, primary sclerosing cholangitis, and auto-immune hepatitis in a Norwegian population[J].Scand J Gastroen-terol, 1998, 33 (1) ∶99-103.
    [2]Puri AS, Kumar N, Gondal R, et al.Primary biliary cirrhosis:an Indi-an experience, Indian[J].J Gastroenterol, 2001, 20 (1) ∶28-29.
    [3]Kananathan R, Suresh RL, Merican I.Primary biliary cirrhosis atHospital Kuala Lumpur:a study of 17 cases seen between 1992 and1999[J].Med J Malaysia, 2002, 57 (1) ∶56-60.
    [4]Yap I, Wee A, Tay HH, et al.Primary biliary birrhosis-an un-common disease in Singapore[J].Singapore Med J, 1996, 37 (1) ∶48-50.
    [5]Sakugawa H, Nakasone H, Nakayoshi T, et al.Epidemiology ofprimary biliary cirrhosis among women with elevated gamma-glu-tamyl transpeptidase levels in Okinawa, Japan[J].Hepatol Res, 2003, 26 (4) ∶330-336.
    [6]Liu HY, Deng AM, Zhang J, et al.Correlation of chlamydia pneu-moniae infection with primary biliary cirrhosis[J].World J Gastro-enterol, 2005, 11 (26) ∶4108-4110.
    [7]Harutal I, Kikuchi K, Hashimoto E, et al.A possible role of his-tone-like DNA-binding protein of Streptococcus intermedius inthe pathogenesis of bile duct damage in primary biliary cirrhosis[J].Clin Immunol, 2008, 127 (2) ∶245-251.
    [8]Rong G, Zhou Y, Xiong Y, et al.Imbalance between Thelper type17 and Tregulatory cells in patients with primary biliary cirrhosis:the serum cytokine profile and peripheral cell population[J].ClinExp Immunol, 2009, 156 (2) ∶217-225.
    [9]Tanaka A, Borchers AT, Ishibashi H, et al.Genetic and familialconsiderations of primary biliary cirrhosis[J].Am J Gastroenterol, 2001, 96 (1) ∶8-15.
    [10]Tsuji K, Watanabe Y, Van de Water J, et al.Familial primary biliar-y cirrhosis in Hiroshima[J].J Autoimmun, 1999, 13 (1) ∶171-178.
    [11]Liu HY, Deng AM, Zhou Y, et al.Analysis of HLAalleles polymor-phism in Chinese patients with primary biliary cirrhosis[J].Hepa-tobiliary Pancreat Dis Int, 2006, 5 (1) ∶129-132.
    [12]Wong RK, Lim SG, Wee A, et al.Primary biliary cirrhosis in Sin-gapore:Evaluation of demography, prognostic factors and naturalcourse in a multi-ethnic population[J].J Gastroenterol Hepatol, 2008, 23 (4) ∶599-605
    [13]Gu EL, Yao GB.The clinical characteristics of primary biliary cir-rhosis in China[J].Chin J Hepatol, 2009, 17∶861-866.
    [14]Sakauchi F, Oura A, Ohnishi H, et al.Comparison of the clinicalfeatures of Japanese patients with primary biliary cirrhosis in 1999and 2004:utilization of clinical data when patients applied to re-ceive public financial aid[J].J Epidemiol, 2007, 17 (6) ∶210-214.
    [15]Talwalkar JA, Lindor KD.Primary biliary cirrhosis[J].Lancet, 2003, 362 (9377) ∶53-61.
    [16]Su CW, Hung HH, Huo TL, et al.Natural history and prognosticfactors of primary biliary cirrhosis in Taiwan:a follow-up study upto 18 years[J].Liver Int, 2008, 28 (9) ∶1305-1313.
    [17]Zhang FK, Jia JD, Wang BE.Clinical evaluation of serum antimito-chondrial antibody-negative primary biliary cirrhosis[J].Hepato-biliary Pancreat Dis Int, 2004, 3 (2) ∶288-291.
    [18]Zhang F, Jia J, Cui R, et al.Clinical features of forty patients withprimary biliary cirrhosis[J].Chin Med J (Engl) , 2002, 115 (6) ∶904-908.
    [19]Sarin SK, Monga R, Sandhu BS, et al.Primary biliary cirrhosis in In-dia[J].Hepatobiliary Pancreat Dis Int, 2006, 5 (1) ∶105-109.
    [20]Sakauchi F, Oura A, Ohnishi H, et al.Comparison of the clinicalfeatures of Japanese patients with primary biliary cirrhosis in 1999and 2004:utilization of clinical data when patients applied to re-ceive public financial aid[J].J Epidemiol, 2007, 17∶210-214.
    [21]Jiang XH, Fang XY, Zhong RQ, et al.Development of an enzymeimmune assay for detecting M2 autoantibodies specific for primarybiliary cirrhosis[J].HBPD Int, 2003, 2 (2) ∶290-294.
    [22]Jiang XH, Zhong RQ, Yu SQ, et a1.Construction and expression ofahumanized M2 autoantigen trimer and its application in the diagno-sis of primary biliary cirrhosis[J].World J Gastroenterol, 2003, 9 (6) ∶1352-1355.
    [23]Chien RN, Sheen IS, Liaw YF.Low prevalence of HBV and HCVinfection in patients with primary biliary cirrhosis in Taiwan:a casecontrol study[J].J Gastroenterol Hepatol, 1993, 8 (6) ∶574-576.
    [24]邵颖, 于中麟, 张澍田.原发性胆汁性肝硬化与病毒性肝炎重叠症八例[J].临床内科杂志, 2002, 19 (3) ∶231-232.
    [25]高峰, 张福奎, 贾继东.国产熊去氧胆酸治疗原发性胆汁性肝硬化患者的随访[J].临床肝胆病杂志, 2008, 24 (4) ∶278-280.
    [26]Wong GL, Hui AY, Wong VW, et al.A retrospective study onclinical features and prognostic factors of biopsy-proven primarybiliary cirrhosis in Chinese patients[J].Am J Gastroenterol, 2005, 100 (10) ∶2205-2211.
    [27]Shibuya A, Tanaka K, Miyakawa H, et al.Hepatocellular carcinomaand survival in patients with primary biliary cirrhosis[J].Hepatolo-gy, 2002, 35 (5) ∶1172-1178.
  • 加载中
计量
  • 文章访问数:  3170
  • HTML全文浏览量:  7
  • PDF下载量:  862
  • 被引次数: 0
出版历程
  • 出版日期:  2010-04-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回